mobile
8th Medical Technology Conference
 
 
Description

The government soon  is coming out with a slew of policy decisions to give a critical push to the medical technology sector as a part of the Make in India program, which include evolving a  regulatory mechanism for the sector through a separate legislation, over hauling tax structure to make the domestic production of medical equipment  more competitive   introducing  purchase preference for boosting local manufacture and stress on Research & Development.

Announcing these measures  at the CII organized 8th Medical Conference with the theme : “A $ 50 billion Medical Technology Industry: Making it Happen in India” held on 28 August, 2015 in Delhi, Dr. VK Subburaj, Secretary, Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India  said that a separate regulatory system for the medical equipment domain could unleash the potential.  For this, he stressed that the sector should have a critical mass and a solid  growth trend.  “Achieving $ 50 billion turnover by 2025 as envisaged by the CII whitepaper would be the right place  for bringing out a separate regulatory mechanism.   The healthcare sector in India would be growing 4 to 5 times from the present level  necessitating a separate body to regulate the industry”, he said.

Dr Subburaj said that Prime Minister’s office is taking a lot of interest in pushing various schemes for boosting the medical equipment production.  It is being monitored regularly and the Department of Pharmaceutical has been empowered to implement the schemes without any loss of time. He also mentioned that the stakeholders like CII have  been giving suggestions on a fast track to bring about reforms in the sector.    With this, it would be possible to come out with the report indicating varous changes that are needed in the sector in three months’ time.

Referring to the anomalies in the tax structure that act against   local manufacturing of medical equipment, the Pharma Secretary said, “This is being examined at the highest level taking inputs from PM’s office, Finance, DIPP and his Department”. We hope to correct these anomalies well in time to create an eco - system for local manufacturing.  The industry has been taking up with the Government the inverted tax structure wherein the import of raw materials is taxed higher than that of finished and semi - finished goods.

Another area which is engaging the attention of the government, Dr Subburaj said was purchase preference for the equipment manufactured by Indian companies.   More than two-third of the medical equipment are imported.  At the same time,  some of the locally manufactured equipment are competitive both in quality and price.  There are 800 units in India across large, medium and small sectors manufacturing medical equipment in the country. With the higher turnover of the healthcare sector, the number of these units would go up in the near future. “We are looking at the tender documents to enable sourcing of equipment locally to give a big boost to medical equipment sector in the country”, he added.

R&D, Dr Subburaj said should engage active attention of all stakeholders including the Government to boost the medical equipment production in the country.  Presently, there are various departments in the Government such as Science and Technology, Biotechnology, various specialized institutions etc. which are involved in R&D and in evolving incentives for innovation and discovery.  He said “We are devising measures for better coordination among these bodies not only for facilitating discoveries and  innovations but also for marketing them,” adding that these activities would be coordinated by Pharmaceutical department. Also, a separate website would be launched so also a Year Book listing out innovations, expertise, discoveries etc. to create an eco - system for boosting  R&D in the segment.

Dr Subburaj underscored that the basic objective of healthcare system was to make treatment affordable and accessible by the people.  Presently, the total number of surgeries done in India are  between 1.5 to 2 lakhs, whereas the demand was for performing 25 lakh surgeries. The reason for not doing the surgeries were either due to lack of facilities for diagnosis  or non-affordability of the patients  for undergoing the costly surgeries.  By making medical system cost effective, there is tremendous scope for expanding the healthcare system, particularly the medical equipment domain.

Earlier, in his welcome address, Mr Himanshu Baid, Chairman, CII Medical Technology Division and MD, Polymedicure Ltd, has laid a roadmap for achieving the potential of the medical equipment segment which is presently dependent on imports to the extent of 70 percent.  These included introduction of regulatory mechanism, a national innovation policy,  strengthening  of manufacturing facilities and plugging capability gaps.

Mr Pavan Choudary, Co-chairman, CII Medical Technology Division and MD, Vygon India Pvt Ltd, said that care has to be taken while correcting the inverted tax structure in the medical technology sector.  A higher customs duty on the import of medical device would lead to proliferation of smuggling from nearby countries thereby endangering patients with devices which do not have adequate legal and service guarantees.

The others who spoke at the meeting included Mr. Rahul Guha, Partner and Director, The Boston Consulting Group and Mr. Suresh Vazirani, CMD, Transasia BioMedicals Ltd. 

Knowledge Resources
You will get access to following Knowledge Resources by subscribing to the Digital Library of this event.
 
Inflow of Higher FDI into Medical Equipment Industry
Medical Technology: Vision 2025 – A CII-BCG Report
Medical Technology: Vision 2025: A CII-BCG Report
National Academy of Drugs for training regulators being set up
Slew of Measures for Boosting Medical Equipment Industry Coming Soon- Pharmaceuticals Secretary
Welcome & Theme Address by Mr Himanshu Baid, MD, Polymedicure Ltd at the inaugural session of the 8th Medical Technology Conference
Medical Technology: Vision 2025 - The $50 Billion Opportunity: Making it Happen
Address by Mr Suresh Vazirani, Chairman and Managing Director, Transasia BioMedicals Ltd., India & ERBA Diagnostics Group of Cos., USA, Europe, Russia at the inaugural session of the 8th Medical Technology Conference
Special address by Dr V K Subburaj, Secretary, Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers at the inaugural session of the 8th Medical Technology Conference
Release of the White Paper “Medical Technology: Vision 2025-The $50 Billion Opportunity: Making it Happen in India” at the inaugural session of the 8th Medical Technology Conference
Concluding address by Mr Pavan Choudary, MD, Vygon India Pvt Ltd at the inaugural session of the 8th Medical Technology Conference
Panel discussion on Need of a Sound Medical Devices Policy-Vision and Actions at the 8th Medical Technology Conference
Opening address by Mr Suresh Vazirani, CMD, Transasia BioMedicals Ltd., India & ERBA Diagnostics Group of Cos., USA, Europe, Russia at the session 'Making India a Manufacturing and Export Hub-Translating Dreams into Reality' of the 8th Medical Technology Conference
Theme address by Mr Sameer Garde, President South Asia, Philips Health Systems at the session Making India a Manufacturing and Export Hub-Translating Dreams into Reality of the 8th Medical Technology Conference
Special address by Mr Sudhanshu Pandey, Joint Secretary, Department of Commerce (TPD), Ministry of Commerce & Industry at the session Making India a Manufacturing and Export Hub-Translating Dreams into Reality at the the 8th Medical Technology Conference
Dr Jitender Kumar Sharma, Head-Division of Healthcare Technology & Director, WHO CC for Priority Medical Devices & Health Technology Policy, National Health Systems Resource Center addressing the session on Making India a Manufacturing and Export Hub-Translating Dreams into Reality at the 8th Medical Technology Conference
Panel discussion on Making India a Manufacturing and Export Hub-Translating Dreams into Reality at the 8th Medical Technology Conference
Panel discussion on Setting up an Enabling Regulatory Framework at the 8th Medical Technology Conference
Panel discussion on Adverse Environment Undermining Make in India at the 8th Medical Technology Conference
Opening address by Mr Himanshu Baid, Chairman, CII Medical Technology Division at the Valedictory session of the 8th Medical Technology Conference
Key takeaways by Mr Pavan Choudary, Co-Chairman, CII Medical Technology Division at the Valedictory session of the 8th Medical Technology Conference
Mr Suresh Vazirani, Chairman and Managing Director, Transasia BioMedicals Ltd., India & ERBA Diagnostics Group of Cos., USA, Europe, Russia addressing at the Valedictory session of the 8th Medical Technology Conference
Special Address by Guest of Honour Mr Krishna Ballabh Agarwal, Additional Secretary, Ministry of Health & Family welfare at the Valedictory session of the 8th Medical Technology Conference
Concluding remarks & vote of thanks by Mr Tejinder Singh Jassal, Country Manager, Molnlycke Health Card India Pvt Ltd at the Valedictory session of the 8th Medical Technology Conference
 
Charges to access Event
 
Participant TypeAmount (in Rs)
Member
2000
NonMember
3000